Glenmark Pharmaceuticals Limited (BOM:532296)
India · Delayed Price · Currency is INR 2,306.00
-19.00 (-0.82%)
At close: Aug 21, 2026
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 654.11 billion as of August 21, 2026. Its market cap has increased by 20.47% in one year.
Market Cap
654.11B
Enterprise Value
648.28B
Revenue
177.37B
Ranking
n/a
PE Ratio
36.38
Stock Price
2,306.00
ChartMarket Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 654.11B, an increase of 56,813.90%. That is a compound annual growth rate of 28.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 654.11B | 13.89% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.86T |
| Lupin | 1.00T |
| Dr. Reddy's Laboratories | 978.76B |
| Abbott India | 557.70B |
| GlaxoSmithKline Pharmaceuticals | 491.21B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 285.49B |
| Granules India | 212.72B |